Colorectal Cancer Coalition

Colorectal Cancer News in Brief: May 15

Despite more resources in large cities, patients were more often diagnosed with cancer at a late stage in cities in Illinois compared to rural areas. Phone calls and personalized diet and exercise plans helped long-term cancer survivors lose weight and gain strength, and scientists have found changes in the blood of family caregivers that promote inflammation and may lead to illness.

In other headlines, both patients and doctors liked virtual, computer videoconferencing visits, and the FDA reports that shortages of fentanyl patches have been resolved.

Research Reports

• Finding cancer at a late stage is more common in Illinois cities than in rural areas. Colorectal, breast, prostate, and lung cancers — are more common in the most densely populated areas of Chicago and follow a pattern of reduced risk as the area population decreases. There was a small increased risk in the most remote rural areas. Researchers used data from Illinois State Cancer Registry from 1998 through 2002. Even after accounting for socioeconomic differences and access to nearby health care facilities, the disparities between city and rural remained. Writing in the early view edition of Cancer published May 11, 2009, geographer Sara McLafferty, Ph.D. said, “The observed pattern of urban disadvantage emphasized the need for more extensive urban-based cancer screening and education programs.”
• Telephone calls and personally tailored printed diet and exercise information reduced the rate of functional decline in older, overweight long-term cancer survivors.  They lost weight and their physical activity, diet, and quality of life improved.  At the beginning of the year-long program both the group in the program and a control group had functional abilities averaging 75.7 on a 100 point scale.  During the year, overall scores declined 2.15 points for survivors in the program compared to a 4.84 loss for the control group.  Leg strength increased,while the control group’s leg function declined further. Program participants were over 65 and had survived cancer for more than five years. Miriam C. Morey, Ph.D. at Duke University reported the results of the study in the May 13, 2009 Journal of the American Medical Association.
• The caregivers of cancer patients show very real changes over time in blood markers of inflammation — both those that promote inflammatory changes and those that protect against it.   Family members caring for patients with a very aggressive form of brain cancer had blood and saliva tested.  A matched group of controls, similar in age and background but free of major life stresses, were also tested.   Psychological tests showed the caregivers were more stressed than the average population and had more depression.  Excess inflammatory response left them vulnerable to heart disease and other illnesses that are triggered by chronic inflammation.  Nicolas Rohleder and  his team from the University of British Columbia published their work in an early online edition of the Journal of Clinical Oncology on May 11, 2009.

Other Headlines

• Virtual visits with a doctor rated well with both patients and doctors.  Patients found talking with a doctor via desktop videoconferencing satisfactory in the time spent with the doctor, personal aspects, and ease of the interaction.  Patients in a study conducted at the Massachusetts General Hospital saw two different doctors, one via teleconferencing and one face-to-face.  They had similar evaluations for both encounters.  Another group saw two different doctors face-to-face without use of telemedicine.  The two doctors agreed on diagnosis 84 percent of the time in the first group, using both teleconferencing and face-to-face visits and 80 percent of the time when they both saw the patient only in their office.   Doctors Ronald Dixon and James Stahl wrote about their study in the Journal of Telemedicine and Telecare.
• The FDA  has announced that the shortage of fentanyl patches has been resolved and that the market is being supplied by five different firms.

This news article was originally posted on May 15th, 2009 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on May 15th, 2009
Tags: caregivers, disparities, FDA, fentanyl, survivorship

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Name Email (hidden) URL Comments (Basic HTML is allowed - a href, strong, em, blockquote)